Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.64 AUD -3.76% Market Closed
Market Cap: 153m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Orthocell Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Orthocell Ltd
Cash Equivalents Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Orthocell Ltd
ASX:OCC
Cash Equivalents
AU$20.6m
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cash Equivalents
AU$35.2m
CAGR 3-Years
-25%
CAGR 5-Years
-8%
CAGR 10-Years
9%
Telix Pharmaceuticals Ltd
ASX:TLX
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Cash Equivalents
AU$66.9m
CAGR 3-Years
54%
CAGR 5-Years
61%
CAGR 10-Years
32%

See Also

What is Orthocell Ltd's Cash Equivalents?
Cash Equivalents
20.6m AUD

Based on the financial report for Jun 30, 2024, Orthocell Ltd's Cash Equivalents amounts to 20.6m AUD.

What is Orthocell Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
13%

Over the last year, the Cash Equivalents growth was -17%. The average annual Cash Equivalents growth rates for Orthocell Ltd have been 8% over the past three years , 13% over the past five years .

Back to Top